CTSO · Cytosorbents Corp
United States · RS rating 89 · As of 2026-10-14
| Price | 3.09 USD |
|---|---|
| 1-day change | -10.7% |
| RS rating (overall / 1M / 3M / 12M) | 89 / 2 / 99 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 49 / 52 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +11.1% |
| Sales growth Q/Q | -2.6% |
| Distance from 52-week high | +54.9% |
| Market cap (USD) | $40.7M |